Contextlogic Holdings is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mark Ward, with a market cap of $215.3M.
Upcoming earnings announcement for Contextlogic Holdings
Past 12 earnings reports for Contextlogic Holdings
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | -$0.52Est: -$0.04 | -1200.0% | - | — | — |
| Oct 28, 2025 | Q3 2025 | -$0.07Est: -$0.04 | -75.0% | - | — | — |
| Aug 7, 2025 | Q2 2025 | -$0.23Est: -$0.04 | -475.0% | - | — | — |
| May 9, 2025 | Q1 2025 | -$0.27Est: -$0.08 | -237.5% | - | — | |
| Mar 12, 2025 | Q4 2024 | -$0.08 | — | - | — | |
| Nov 7, 2024 | Q3 2024 | -$0.04Est: -$0.01 | -300.0% | -Est: $51.9M | -100.0% | |
| Aug 8, 2024 | Q2 2024 | -$0.50Est: -$0.06 | -733.3% | $7.0MEst: $1.7M | +302.3% | |
| May 8, 2024 | Q1 2024 | -$2.43Est: -$1.58 | -53.8% | $36.0MEst: $56.0M | -35.7% | |
| Mar 4, 2024 | Q4 2023 | -$2.82Est: -$2.66 | -6.0% | $53.0MEst: $53.1M | -0.1% | |
| Nov 7, 2023 | Q3 2023 | -$3.35Est: -$3.31 | -1.2% | $60.0MEst: $57.4M | +4.6% | — |
| Aug 3, 2023 | Q2 2023 | -$3.38Est: -$3.74 | +9.6% | $78.0MEst: $94.3M | -17.2% | |
| May 4, 2023 | Q1 2023 | -$3.83Est: -$3.80 | -0.8% | $96.0MEst: $115.9M | -17.2% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.